- Previous Close
357.05 - Open
357.00 - Bid --
- Ask --
- Day's Range
354.60 - 359.85 - 52 Week Range
314.00 - 401.00 - Volume
90,251 - Avg. Volume
222,167 - Market Cap (intraday)
49.671B - Beta (5Y Monthly) 0.33
- PE Ratio (TTM)
103.92 - EPS (TTM)
3.43 - Earnings Date May 29, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
328.33
HealthCare Global Enterprises Limited, together with its subsidiaries, provides healthcare services focusing on cancer and fertility. The company offers cancer diagnosis and treatment services through radiation therapy, medical oncology, and surgery; and fertility treatment services, as well as reproductive medicine services, including assisted reproduction, gynecological endoscopy, and fertility preservation under the Milann brand. It also operates multi-specialty hospitals under the HCG brand in Ahmedabad, Bhavnagar, and Rajkot in the state of Gujarat; operations and management contract in Hubli in the state of Karnataka that primarily provide cardiology, neurology, orthopaedics, gastroenterology, urology, internal medicine, and pulmonary and critical care. In addition, the company offers medical diagnostic services, including scientific testing and consultancy services in the pharmaceutical and medical sector. It operates cancer centers. The company was founded in 1989 and is based in Bengaluru, India.
www.hcgoncology.comRecent News: HCG.NS
View MorePerformance Overview: HCG.NS
Trailing total returns as of 7/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HCG.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HCG.NS
View MoreValuation Measures
Market Cap
49.75B
Enterprise Value
59.40B
Trailing P/E
104.10
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.63
Price/Book (mrq)
6.03
Enterprise Value/Revenue
3.11
Enterprise Value/EBITDA
16.93
Financial Highlights
Profitability and Income Statement
Profit Margin
2.52%
Return on Assets (ttm)
3.86%
Return on Equity (ttm)
4.76%
Revenue (ttm)
19.12B
Net Income Avi to Common (ttm)
481.4M
Diluted EPS (ttm)
3.43
Balance Sheet and Cash Flow
Total Cash (mrq)
3.03B
Total Debt/Equity (mrq)
147.31%
Levered Free Cash Flow (ttm)
620.28M